Login
← Go Back
Ajanta Pharma
AJANTPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: Mannalal B Agrawal · MD: Yogesh M Agrawal · Listing date: June 1, 2000 · Employees: 7035 · Mumbai · http://www.ajantapharma.com
Stock Price vs Company Growth
1d
2.3%
1w
5.2%
1m
7.8%
3m
1.4%
6m
19.3%
1y
18.3%
5y
19.2%
10y
12.5%
all
38.7%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 3,024 2.3%
2,697
3,315
Company Overview
Sales
5,453 Cr
Growth: 14.1%
Profit after Tax
1,056 Cr
Growth: 4.1%
Large Cap
37,787 Cr
P/E: 35.8x
Industry P/E: 31.1x
Fundamentals
Sales (Cr) ₹ 5,453
Growth 14.1%
EBITDA 25.6%
P/S 6.9x
Dividend 1.1%
P/E 35.8x
Book Value ₹ 362
PEG Ratio 2.5x
ROE 24.2%
P/B 8.3x
Shareholding Pattern
Institutions
Uti Flexi Cap Fund
3.46 %
Mirae Asset Emerging Bluechip Fund
3.41 %
Sbi Magnum Global Fund
1.28 %
Llp
0.08 %
Iepf
0.06 %
Promoters
Rajesh M Agrawal, Trustee Rajesh Agrawal Trust
14.48 %
Yogesh M Agrawal, Trustee Yogesh Agrawal Trust
14.48 %
Ravi P Agrawal, Trustee Ravi Agrawal Trust
14.37 %
Aayush M Agrawal, Trustee Aayush Agrawal Trust
14.36 %
Gabs Investments Pvt Ltd
9.7 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. Its business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.
Belongs to (30 Indices) view more
Investors (133)
sbi.magn...
marshall...
motilal....
Followers (28)
nitin2
keerthi
deepak